https://youtu.be/4mUox4WUgKo
https://youtu.be/hHhnBCh3JVY
WHO warns against mixing and matching Covid vaccines
https://youtu.be/uOSg56T73Zs
BACA SELANJUTNYA: https://www.thethirdforce.net/ lawyer-matthias-chang-accuses- khairy-noor-hisham-of- complicity-in-covid-19-scam- bigger-than-1mdb/
Individuals fully vaccinated using the Sinovac Covid-19 vaccine at least three months ago will soon be eligible for a Pfizer-BioNTech booster shot.
This exercise of administering heterologous booster shots - meaning the booster vaccine used is different from the first vaccine - will be done in an off-label and voluntary manner. It will also be part of a government study.
Off-label is when a drug is used in a way other than officially approved for.
Health Minister Khairy Jamaluddin announced this in a press conference this evening.
“The Health Ministry has decided to extend the booster dose to individuals who have received complete Sinovac doses at least three months ago, whereby they will be given a Comirnaty booster dose in a heterologous manner,” he said.
Comirnaty is the name of the Covid-19 vaccine by Pfizer-BioNTech.
Elderly first
Khairy noted that these heterologous booster shots will be rolled out in phases nationwide.
The first phase will begin tomorrow (Oct 22) and prioritise those 60 years old and above who were fully vaccinated using Sinovac at least three months ago.
He said eligible participants will be informed via MySejahtera or text message.
He also said the ministry will soon launch an appointment-booking system for booster shots.
These shots will be administered by private healthcare providers and managed by ProtectHealth Corporation Sdn Bhd.
“Administering heterologous booster doses is an off-label use and will be used as a subgroup study in The Real World Evaluation of Covid-19 Vaccination (RECoVaM) and a study of the adverse serious effects after vaccination (SafeCovac) for all booster dose recipients.
“Booster doses will be administered in a voluntary and free manner under the National Covid-19 Immunisation Programme.
“The objective of administering booster doses of the Covid-19 vaccine is to ensure optimum protection period is obtained by all Covid-19 vaccine recipients,” he explained.
RECoVaM is a study by the ministry’s Institute for Clinical Research at the National Institute of Health (NIH).
SafeCovac is also a study by the NIH
Pfizer booster dose to be given to Sinovac vaccine recipients
Health Minister Khairy Jamaluddin said the dispensing of the heterologous booster dose is through off-label manner and would be given to eligible recipients of Sinovac vaccine from tomorrow in phases nationwide.
"For the start, the booster shot would be administered on individuals aged 60 and above based on the advice of Strategic Advisory Group Experts on Immunisation (SAGE) from the World Health Organisation (WHO) which met on Oct 4 to 7.
"The dispensing would become a subgroup study in the study of The Real World Evaluation of COVID-19 Vaccination (RECoVaM) and the study on Serious Adverse Effects After Vaccination (SAFECOVAC) which is for all booster dose recipients," he said in a media conference today.
Khairy said the administering of the booster dose is voluntary and free under National COVID-19 Immunisation Programme (PICK) with the objective to ensure optimum protection for COVID-19 recipients in Malaysia.
He said the initiative would be led by private medical practitioners under the coordination of Protect Health Corporation Sdn Bhd.
"Eligible Individuals would be informed via MySejahtera application and through Short Message Service (SMS) to the telephone number of the individuals who do not have MySejahtera.
"The method of booster dose appointment would be improved from time to time and soon vaccine recipients would be able to make appointment through a system being developed by MOH," he said.
Earlier, the Health Minister said the implementation of the booster dose had begun nationwide on Oct 13 using Comirnaty vaccine involving 47,728 recipients as at Oct 19.
He said at the moment, the booster dose is given to recipients of Comirnaty vaccine at least after six months with priority given to frontliners (health and security), residents aged 60 and above and individual with comorbidity
On the pandemic situation for the 41st epid week (Oct 10 to 16), Khairy said the total admission of COVID-19 patients to public hospitals and COVID-19 Quarantine and Low-Risk Treatment Centres (PKRC) for the Central Zone ( Selangor, Kuala Lumpur and Putrajaya) has started to show a rising trend after interstate travel was allowed on Oct 11.
He said the situation is also the same in Sarawak especially for Category 3,4 and 5 patients after cross state travel was allowed.
"Similarly, the trend of COVID-19 patients in categories 3,4 and 5 in the Southern Zone in which Negeri Sembilan had started to show an increasing trend in the 40th epidemic week," he said.
Meanwhile, Khairy also announced the launch of COVID-19 National Testing Strategy would study the test strategy for COVID-19 which is clearer such as the context needed for COVID-19 test.
He said the document would be uploaded into MOH website tomorrow morning.
"... at the work place, school, university, concert, conference, stadium and so on by clearly stating when you need to be tested, how often you need to be tested. The launch (strategy) would give a clearer picture to the people on when one should carry out COVID-19 test and in what context one should take the COVID-19 test," he said.
-- BERNAMA
Related:
MySJ明天开始通知!凯里:接种科兴(Sinovac)3个月后必须混打「加强针」Pfizer疫苗! https://rojaklah.com/2021/10/
How effective is Sinovac vaccine? Here are some lessons from other countries
Interstate rush: Penang expecting an influx of 50,000 tourists this weekend and MBPP freezes staff leave ...
Penang Mayor Datuk Yew Tung Seang says the island welcomes both visitors and locals returning home to meet their families after a long travel hiatus. – The Vibes file pic, October 13, 2021